The recent U.S. Supreme Court decision that ruled human genes cannot be patented may provide greater access to genetic testing. (posted Sept. 24, 2013)
Lactoferricin’s Role in Preventing Disc Degeneration
The combination of bone-morphogenetic protein-7 (BMP7) and lactoferricin B (LfcinB) may be a useful treatment for disc degeneration. (posted Sept. 16, 2013)
Sensory Nerves May Be Key for Osteoporosis
Sensory nerves have an essential role in bone remodeling. In particular, semaphorin 3A (Sema3A) regulates bone remodeling by modulating sensory nerve development. (posted Sept. 9, 2013)
Speak Out Rheum: Under the Radar
A physician–patient’s experience with Sjögren’s syndrome
SGR Fix Finally on the Horizon?
By a 51–0 vote, the House Energy and Commerce Committee in July passed H.R. 2810, legislation that would repeal the Sustainable Growth Rate (SGR) formula. (posted Sept. 9, 2013)
RA Treatment Options Expanded with New Infusible TNF Inhibitor
FDA approves second infusible anti–tumor necrosis factor treatment for patients with moderate to severe rheumatoid arthritis. (posted Aug. 16, 2013)
American College of Rheumatology Backs Bill to Prevent Cuts to Infusion Reimbursement
The ACR has endorsed a proposed law that would exempt physician-administered drugs from future Medicare sequestration. (posted Aug. 21, 2013)
New Methodology to Improve Cartilage Repair
A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells. (posted July 31, 2013)
B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)
Congress Considers More Regulation for Manufacturers of Compounding Drugs
New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)
- « Previous Page
- 1
- …
- 307
- 308
- 309
- 310
- 311
- …
- 317
- Next Page »